We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cancer cells.
Product News

Enpicom Partners With Erasmus University Medical Center in Groundbreaking Effort To Discover Nanobodies Against Cancer

Erasmus University Medical Center uses ENPICOM’s IGX Platform and services to advance their research on identifying cancer nanobodies.
An antibody attacking a viral protein.
Product News

Beckman Coulter Life Sciences Achieves Industry-First With Commercial Release of Anti-TRBC2 Conjugated Antibody for Flow Cytometry

New advancement builds on 25-year commitment to T-Cell research.
A scientist pipetting into an agar plate.
Product News

Thermo Fisher Scientific Introduces New Sample Preparation Solutions To Simplify and Automate Respiratory Diagnostic Testing

New Thermo Scientific KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit improve preanalytical workflows for clinical laboratories.
Vials of blood.
Product News

Oxford Nanopore and Day Zero Diagnostics Partner To Develop a New Class of Bloodstream Infection Diagnostics

Oxford Nanopore, and Day Zero Diagnostics (DZD), announced a collaboration to develop an end-to-end solution for the diagnosis of bloodstream infections, a leading cause of sepsis.
A hand holding a pair of tweezers, plucking a section of DNA.
Product News

Tune Therapeutics Reveals Epigenetic Editing Program Targeting Hepatitis B Virus

The mechanism targets both integrated virus and cccDNA; expected to begin clinical testing by end of 2024. Preclinical program data to be presented at the 2023 Hep DART Conference .
A worker in a lab.
Product News

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria

Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
Advertisement